Skip to main content
Figure 1 | BMC Gastroenterology

Figure 1

From: Efficacy, safety and cost analyses in ulcerative colitis patients undergoing granulocyte and monocyte adsorption or receiving prednisolone

Figure 1

This figure shows time to the disappearance of at least one major ulcerative colitis (UC) symptoms (diarrhoea, rectal bleeding, and abdominal discomfort) as well as time to remission (clinical activity index, CAI≤4) following the start of interventions. As shown, no statistically significant (ns) difference between the patients who received the corticosteroid, PSL and those who received the non-pharmacologic, GMA was found.

Back to article page